23andMe Investor Presentation Deck

Consumer Powered Healthcare Flywheel We run hundreds of billions of association tests per year that further our unique understanding of human biology Consumer 13.1M Genotyped Customers¹ KK Data 80% Opt-In to Research Research lolli Phenotypic Data XX 1. As of June 30, 2022. 2. As of March 31, 2022. Programs include collaborated, 100% owned and royalty interest targets. Genetic Data Insights 4B+ Phenotypic Data Points² Innovative Results Return value to the Customer Therapeutics / Product Drug Discoveries 50+ Programs² Copyright © 2022 23and Me, Inc. Novel Consumer Products >>> 23andMe 12

View entire presentation